We are live on ! Find out more
AKBA icon

Akebia Therapeutics
AKBA

57 hedge funds and large institutions have $94.4M invested in Akebia Therapeutics in 2014 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

265% more call options, than puts

Call options by funds: $391K | Put options by funds: $107K

100% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 8

46% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 13

12% more funds holding

Funds holding: 51 → 57 (+6)

44% less capital invested

Capital invested by funds: $170M → $94.4M (-$75.4M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
57
Holders Change
+6
Holders Change %
+11.76%
% of All Funds
1.52%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
16
Increased
19
Reduced
13
Closed
8
Calls
$391K
Puts
$107K
Net Calls
+$284K
Net Calls Change
-$1.54M

Top Buyers

1
EAM
Eagle Asset Management
Florida
+$11.2M
2
BFA
BlackRock Fund Advisors
California
+$3.86M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$3.28M
4
Millennium Management
Millennium Management
New York
+$1M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$964K

Top Sellers

1
Franklin Resources
Franklin Resources
California
-$4.8M
2
CAM
Cormorant Asset Management
Massachusetts
-$4.04M
3
Jennison Associates
Jennison Associates
New York
-$3.97M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.95M
5
EAM
Eventide Asset Management
Massachusetts
-$3.68M
Name Holding Trade Value Shares
Change 		Change in
Stake
Swiss National Bank
26
Swiss National Bank
Switzerland
$200K +$247K +17,200 New
ProShare Advisors
27
ProShare Advisors
Maryland
$176K +$217K +15,152 New
TC
28
TFS Capital
Pennsylvania
$171K -$100K -6,980 -32%
D.E. Shaw & Co
29
D.E. Shaw & Co
New York
$170K +$209K +14,584 New
California State Teachers Retirement System (CalSTRS)
30
California State Teachers Retirement System (CalSTRS)
California
$169K +$889 +62 +0.4%
DP
31
Dearborn Partners
Illinois
$167K +$205K +14,320 New
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$159K +$196K +13,684 New
Connor, Clark & Lunn Investment Management (CC&L)
33
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$159K +$196K +13,700 New
Charles Schwab
34
Charles Schwab
California
$134K -$77.7K -5,419 -32%
UBS Group
35
UBS Group
Switzerland
$134K +$165K +11,481 New
Group One Trading
36
Group One Trading
Illinois
$132K +$160K +11,142 +4,721%
TA
37
Teachers Advisors
New York
$129K – – –
ARTA
38
A.R.T. Advisors
New York
$119K +$148K +10,290 New
Deutsche Bank
39
Deutsche Bank
Germany
$115K +$142K +9,899 +13,749%
Wells Fargo
40
Wells Fargo
California
$80K +$81.1K +5,653 +432%
Citigroup
41
Citigroup
New York
$65K +$76.5K +5,334 +1,891%
AIG
42
American International Group
New York
$57.3K -$2.8K -195 -4%
Fifth Third Bancorp
43
Fifth Third Bancorp
Ohio
$50K – – –
BA
44
BlackRock Advisors
Delaware
$38K – – –
SO
45
STRS Ohio
Ohio
$31K – – –
AllianceBernstein
46
AllianceBernstein
Tennessee
$27K -$18.6K -1,300 -36%
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$24K +$12.2K +850 +68%
TRCT
48
Tower Research Capital (TRC)
New York
$13K +$16.6K +1,159 New
MA
49
MCF Advisors
Kentucky
$11K – – –
MA
50
MUFG Americas
New York
$7K +$8.46K +590 New
1
2
3

AKBA Hedge Fund Activity: Q4 2014 in Review

57 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Akebia Therapeutics (AKBA) for Q4 2014, worth a combined $94.4M — down 44% from $170M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new AKBA positions and 8 closed out — a net gain of 8 holders — while 19 added to existing stakes and 13 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $11.2M. The largest seller was Franklin Resources, cutting an estimated $4.8M.

  • 57 institutional investors held Akebia Therapeutics (AKBA) as of Q4 2014, up from 51 in Q3 2014.
  • Funds reported $94.4M of Akebia Therapeutics stock for Q4 2014, down 44% quarter-over-quarter.
  • 16 funds opened new Akebia Therapeutics positions in Q4 2014 and 8 closed out, a net change of +8 holders.
  • The largest Akebia Therapeutics buyer in Q4 2014 was Eagle Asset Management, an estimated $11.2M added.
  • The largest Akebia Therapeutics seller in Q4 2014 was Franklin Resources, an estimated $4.8M sold.

Based on aggregated 13F filings for Q4 2014.